reported side effects of tenofovir
abdominal pain
depression
nausea
vomiting
vesicobullous reaction
other side effects
pneumonia
bone mineral density
comprehensive list of adverse effects
needed effects
tenofovir
unwanted side effects
medical attention
following side effects
taking tenofovir
check
doctor
tenofovir side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
controlled clinical trials
common side effects
tenofovir disoproxil fumarate
df
hiv
infected patients
rash
diarrhea
headache
pain
depression
asthenia
nausea
common side effects
drug in combination with other antiretrovirals
moderate gastrointestinal events
nausea
diarrhea
vomiting
flatulence
therapy-experienced patients
moderate gastrointestinal events
dizziness in therapy-naive patients
patients in clinical trials
discontinued therapy
gastrointestinal side effects
controlled clinical trials
common side effects
tenofovir df in patients with chronic hepatitis b virus
hbv
infection
compensated liver disease
nausea
abdominal pain
diarrhea
headache
dizziness
fatigue
nasopharyngitis
pain
skin rash
patients with chronic hbv
decompensated liver disease
common side effects
controlled trial
abdominal pain
nausea
insomnia
pruritus
vomiting
dizziness
pyrexia
abdominal pain
severity
nausea
severity
vomiting
severity
patients with chronic hbv
decompensated liver disease
n =-rrb-
pancreatitis
abdominal pain
elevated amylase
postmarketing experience
abdominal pain
nausea
diarrhea
vomiting
elevated serum amylase
flatulence
dyspepsia
abdominal distension
upper abdominal painuncommon
pancreatitis
elevated serum lipase
serum phosphorus
mg/dl
patient with chronic hbv
decompensated liver disease
lactic acidosis
steatosis
including
fatal cases
use of nucleoside analogs
hypokalemia
hypophosphatemia
result of proximal renal tubulopathy
lactic acidosis
hypokalemia
hypophosphatemia
postmarketing experience
elevated fasting cholesterol
elevated triglycerides
hypophosphatemiacommon
elevated fasting triglycerides
anorexia
elevated serum glucose/hyperglycemia
elevated alkaline phosphataseuncommon
hypokalemiarare
lactic acidosisfrequency
serum phosphorus
mg/dl
vitamin d levelsantiretroviral therapy
frequency
redistribution/accumulation of body fat
including
central obesity
dorsocervical fat enlargement
peripheral wasting
facial wasting
breast enlargement
cushingoid appearance
increased blood lipid levels
glucose levels
rash event
including rash
pruritus
maculopapular rash
urticaria
vesiculobullous rash
pustular rash
exfoliative rash
generalized rash
macular rash
pruritic rash
vesicular rash
pruritus
sweatinguncommon
lipodystrophyrare
angioedemafrequency
lichenoid drug eruption with eosinophilia
pruritus
severity
patients with chronic hbv
decompensated liver disease
n =-rrb-
rash
postmarketing experience
insomnia
severity
patients with chronic hbv
decompensated liver disease
n =-rrb-
insomnia
depression
anxiety
abnormal dreams
headache
dizziness
peripheral neuropathy
including
peripheral neuritis
neuropathy
frequency
somnolence
paresthesia
dizziness
severity
patients with chronic hbv
decompensated liver disease
n =-rrb-
pyrexia
severity
patients with chronic hbv
decompensated liver disease
n =-rrb-
asthenia
postmarketing experience
pain
pyrexia/fever
asthenia
fatigue
weight loss
chest pain
procedural painantiretroviral therapy
frequency
increased weight
elevated creatine kinase
arthralgia
myalgia
painuncommon
rhabdomyolysis
muscular weaknessrare
myopathyfrequency
decreased bone mineral density
biochemical markers of bone metabolism
serum
bone-specific alkaline phosphatase
serum osteocalcin
serum c telopeptide
urinary n telopeptide
relevant fractures
excluding fingers
toes
bone abnormalities
contributing
fractures
osteonecrosispostmarketing reports
osteomalacia
bone pain
fractures
rhabdomyolysis
osteomalacia
muscular weakness
myopathy
result of proximal renal tubulopathy
rhabdomyolysis
muscular weakness
myopathy
postmarketing experience
death
progression of liver disease
patients with chronic hbv
decompensated liver disease
n =-rrb-
on-treatment alt
hepatic flares
patients with chronic hbv
alt flares
weeks of therapy
decreases in hbv-dna levels
weeks without changes
therapy
severe acute exacerbations of hepatitis
patients with hepatitis b after discontinuation of this drug
lactic acidosis
steatosis
including
fatal cases
use of nucleoside analogs
hepatic steatosis
hepatitis
postmarketing experience
elevated transaminases
elevated alt
elevated ast
death
progression of liver diseaserare
hepatic steatosis
hepatitisfrequency
on-treatment alt
hepatic flares
lactic acidosis/severe
steatosis
including
fatal cases
severe acute exacerbations of hepatitispostmarketing reports
elevated liver enzymes
ast
alt
gamma glutamyltransferase
increase in serum creatinine of mg/dl
patients with chronic hbv
decompensated liver disease
n =-rrb-
tenofovir
decompensated liver disease
impact on renal function
contribution of tenofovir
renal impairment in these patients
proximal renal tubulopathy
drug
crcl
patients
stopping tenofovir df
rhabdomyolysis
osteomalacia
bone abnormalities
contributing
fractures
hypokalemia
muscular weakness
myopathy
hypophosphatemia
result of proximal renal tubulopathy
renal failure
acute renal failure
fanconi syndrome
proximal renal tubulopathy
creatinine
nephrogenic diabetes insipidus
acute tubular necrosis
postmarketing experience
increased creatinineuncommon
proximal renal tubulopathy
including
fanconi syndrome
acute renal failure
renal failure
acute tubular necrosis
nephrogenic diabetes insipidusfrequency
new onset
worsening
worsening renal impairment
nephritis
crclpostmarketing reports
renal insufficiency
interstitial nephritis
including
acute cases
sinusitis
upper respiratory tract infections
nasopharyngitis
pneumonia
pharyngolaryngeal painfrequency
nasal congestionpostmarketing reports
dyspnea
decreased neutrophils
hematuria
glycosuriafrequency
decreased urine volumepostmarketing reports
proteinuria
polyuria
postmarketing reports
allergic reaction
including angioedema
frequency
higher serum
parathyroid hormone levels
frequency
immune reconstitution syndrome
autoimmune disorders in the setting of immune reconstitution
graves
disease
polymyositis
guillain-barre syndrome
side effects of tenofovir
fda
healthcare professional for medical advice
chest pain
cough
fever or chills
tightness in the chest
troubled breathing
stomach discomfort
decreased appetite
diarrhea
fast, shallow breathing
general feeling of discomfort
muscle pain
cramping
unusual tiredness
weakness
agitation
bone pain
changes in urination
confusion
convulsions or seizures
depression
fast heartbeat
increased blood pressure
increased thirst
muscle twitching
pains in the stomach
side
abdomen
radiating
back
stupor
swelling of the face
fingers
lower legs
vomiting
weight gain
yellow eyes
skin
back pain
lack
loss of strength
pain
redness of the skin
skin rash
itching skin
hives
welts
burning
crawling
itching
numbness
prickling
pins
needles
tingling feelings
heartburn or indigestion
joint pain
swelling
muscle pains
stiffness
passing of gas
redistribution
accumulation of body fat
weight loss